The Impedimed (ASX:IPD) share price rocketed 13% today. Here’s why

The Impedimed Limited (ASX: IPD) share price was off to a flying start this morning, up 13% at market open.

The positive price movement came as the medical technology company announced it received Food and Drug Administration (FDA) clearance for a new heart monitoring device in the United States.

At the time of writing, shares in the company are up 8.7%, trading at 12.5 cents. By comparison, the S&P/ASX All Ordinaries Index (ASX: XAO) is 0.08% higher.

Let’s take a closer look at today’s news and what it means for the Impedimed share price.

Impedimed’s new product

In a statement to the ASX, Impedimed advised it has received FDA…